{"doc_id": "33607104", "type of study": "Therapy", "title": "", "abstract": "No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial.\nThe aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19).\nThe study included 50 patients who were randomly assigned to the dexamethasone group or control group.\nDexamethasone was administered at a dose of 20\u00a0mg/day from day 1-5 and then at 10\u00a0mg/day from day 6-10.\nThe need for invasive mechanical ventilation, death rate, duration of clinical improvement, length of hospital stay, and radiological changes in the computed tomography scan were assessed.\nThe results revealed that 92% and 96% of patients in the dexamethasone and control groups, respectively, required noninvasive ventilation (P\u00a0=\u00a00.500).\nAmong them, 52% and 44% of patients in the dexamethasone and control groups, respectively, required invasive mechanical ventilation (P\u00a0=\u00a00.389).\nAt the end of the study, 64% of patients in the dexamethasone group and 60% of patients in the control group died (P\u00a0=\u00a00.500); the remaining patients were discharged from the hospital during the 28-day follow-up period.\nThe median length of hospital stay was 11 days in the dexamethasone group and 6 days in the control group (P\u00a0=\u00a00.036) and the median length of hospital stay was 7 days in the dexamethasone group and 3 days in the control group (P\u00a0<\u00a00.001).\nNo significant differences were observed in the other outcomes.\nThis study showed that corticosteroid administration had no clinical benefit in patients with COVID-19-induced mild to moderate ARDS.\nCopyright \u00a9 2021 Elsevier B.V. All rights reserved.\n", "Evidence Map": {"Enrollment": [{"term": "COVID-19", "negation": "negated", "UMLS": {}, "start": 80, "end": 88}, {"term": "mild to moderate acute respiratory distress syndrome ( ARDS )", "negation": "affirmed", "UMLS": {}, "start": 108, "end": 169}, {"term": "coronavirus disease", "negation": "affirmed", "UMLS": {}, "start": 177, "end": 196}, {"term": "COVID-19-induced mild to moderate ARDS", "negation": "negated", "UMLS": {}, "start": 94, "end": 132}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "No clinical benefit of high dose corticosteroid administration in patients with COVID-19 : A preliminary report of a randomized clinical trial .", "Evidence Elements": {"Participant": [{"term": "COVID-19", "negation": "negated", "UMLS": {}, "start": 80, "end": 88}], "Intervention": [{"term": "high dose corticosteroid administration", "negation": "negated", "UMLS": {}, "start": 23, "end": 62, "has_chemical": [{"text": "corticosteroid", "maps_to": "C3536709:Corticosteroid", "start": 10, "end": 24, "has_dosage": ["high dose"]}], "has_relation": "N/A"}], "Outcome": [{"term": "clinical benefit", "negation": "negated", "UMLS": {}, "start": 3, "end": 19}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome ( ARDS ) due to coronavirus disease 2019 ( COVID-19 ) .", "Evidence Elements": {"Participant": [{"term": "mild to moderate acute respiratory distress syndrome ( ARDS )", "negation": "affirmed", "UMLS": {}, "start": 108, "end": 169}, {"term": "coronavirus disease", "negation": "affirmed", "UMLS": {}, "start": 177, "end": 196}], "Intervention": [{"term": "dexamethasone administration", "negation": "affirmed", "UMLS": {}, "start": 62, "end": 90, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The study included 50 patients who were randomly assigned to the dexamethasone group or control group .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 65, "end": 78, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 88, "end": 95, "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Dexamethasone was administered at a dose of 20 mg / day from day 1-5 and then at 10 mg / day from day 6-10 .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "Dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 13, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The need for invasive mechanical ventilation , death rate , duration of clinical improvement , length of hospital stay , and radiological changes in the computed tomography scan were assessed .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "need for invasive mechanical ventilation", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 44}, {"term": "death rate", "negation": "affirmed", "UMLS": {}, "start": 47, "end": 57}, {"term": "duration of clinical improvement", "negation": "affirmed", "UMLS": {}, "start": 60, "end": 92}, {"term": "length of hospital stay", "negation": "affirmed", "UMLS": {}, "start": 95, "end": 118}, {"term": "radiological changes", "negation": "affirmed", "UMLS": {}, "start": 125, "end": 145}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The results revealed that 92 % and 96 % of patients in the dexamethasone and control groups , respectively , required noninvasive ventilation ( P = 0.500 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 59, "end": 72, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 77, "end": 84, "has_relation": "N/A"}], "Outcome": [{"term": "noninvasive", "negation": "affirmed", "UMLS": {}, "start": 118, "end": 129}], "Observation": [], "Count": [{"term": "92 %", "negation": "affirmed", "UMLS": {}, "start": 26, "end": 30}, {"term": "96 % of patients", "negation": "affirmed", "UMLS": {}, "start": 35, "end": 51}]}, "Evidence Propositions": [{"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "", "Count": "92 %", "Outcome": "noninvasive"}, {"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "", "Count": "96 % of patients", "Outcome": "noninvasive"}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "", "Count": "96 % of patients", "Outcome": "noninvasive"}]}, {"Section": "UNKNOWN", "Text": "Among them , 52 % and 44 % of patients in the dexamethasone and control groups , respectively , required invasive mechanical ventilation ( P = 0.389 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 46, "end": 59, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 64, "end": 71, "has_relation": "N/A"}], "Outcome": [{"term": "invasive", "negation": "affirmed", "UMLS": {}, "start": 105, "end": 113}], "Observation": [], "Count": [{"term": "52 %", "negation": "affirmed", "UMLS": {}, "start": 13, "end": 17}, {"term": "44 % of patients", "negation": "affirmed", "UMLS": {}, "start": 22, "end": 38}]}, "Evidence Propositions": [{"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "", "Count": "52 %", "Outcome": "invasive"}, {"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "", "Count": "44 % of patients", "Outcome": "invasive"}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "", "Count": "44 % of patients", "Outcome": "invasive"}]}, {"Section": "UNKNOWN", "Text": "At the end of the study , 64 % of patients in the dexamethasone group and 60 % of patients in the control group died ( P = 0.500 ) ; the remaining patients were discharged from the hospital during the 28-day follow-up period .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 50, "end": 63, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 98, "end": 105, "has_relation": "N/A"}], "Outcome": [{"term": "died", "negation": "affirmed", "UMLS": {}, "start": 112, "end": 116}, {"term": "discharged from the", "negation": "affirmed", "UMLS": {}, "start": 161, "end": 180}], "Observation": [], "Count": [{"term": "64 % of patients", "negation": "affirmed", "UMLS": {}, "start": 26, "end": 42}, {"term": "60 % of patients", "negation": "affirmed", "UMLS": {}, "start": 74, "end": 90}, {"term": "remaining patients", "negation": "affirmed", "UMLS": {}, "start": 137, "end": 155}]}, "Evidence Propositions": [{"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "", "Count": "64 % of patients", "Outcome": "died"}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "", "Count": "60 % of patients", "Outcome": "died"}]}, {"Section": "UNKNOWN", "Text": "The median length of hospital stay was 11 days in the dexamethasone group and 6 days in the control group ( P = 0.036 ) and the median length of hospital stay was 7 days in the dexamethasone group and 3 days in the control group ( P < 0.001 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 54, "end": 67, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 99, "has_relation": "N/A"}, {"term": "dexamethasone", "negation": "affirmed", "UMLS": {}, "start": 54, "end": 67, "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 92, "end": 99, "has_relation": "N/A"}], "Outcome": [{"term": "median length of hospital stay", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 34}, {"term": "median length of hospital stay", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 34}], "Observation": [{"term": "11 days", "negation": "affirmed", "UMLS": {}, "start": 39, "end": 46}, {"term": "6 days", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 84}, {"term": "7 days", "negation": "affirmed", "UMLS": {}, "start": 163, "end": 169}, {"term": "3 days", "negation": "affirmed", "UMLS": {}, "start": 201, "end": 207}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "11 days", "Outcome": "median length of hospital stay", "Count": ""}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "6 days", "Outcome": "median length of hospital stay", "Count": ""}, {"Intervention": {"term": "dexamethasone", "has_chemical": [{"text": "dexamethasone", "maps_to": "C0011777:dexamethasone", "start": 0, "end": 13}], "has_relation": "N/A"}, "Observation": "7 days", "Outcome": "median length of hospital stay", "Count": ""}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "3 days", "Outcome": "median length of hospital stay", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "No significant differences were observed in the other outcomes .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "other outcomes", "negation": "negated", "UMLS": {}, "start": 48, "end": 62}], "Observation": [{"term": "significant differences", "negation": "affirmed", "UMLS": {}, "start": 3, "end": 26}], "Count": []}, "Evidence Propositions": [{"Intervention": [], "Observation": "significant differences", "Outcome": "other outcomes", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "This study showed that corticosteroid administration had no clinical benefit in patients with COVID-19-induced mild to moderate ARDS .", "Evidence Elements": {"Participant": [{"term": "COVID-19-induced mild to moderate ARDS", "negation": "negated", "UMLS": {}, "start": 94, "end": 132}], "Intervention": [{"term": "corticosteroid", "negation": "affirmed", "UMLS": {}, "start": 23, "end": 37, "has_chemical": [{"text": "corticosteroid", "maps_to": "C3536709:Corticosteroid", "start": 0, "end": 14}], "has_relation": "N/A"}], "Outcome": [{"term": "clinical benefit", "negation": "negated", "UMLS": {}, "start": 60, "end": 76}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Copyright \u00a9 2021 Elsevier B.V . All rights reserved .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}